{"id":"W4296962943","doi":"10.1016/s2152-2650(22)00747-9","title":"Poster: AML-484 First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab + Azacitidine + Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; McGill University; University of Toronto; Jewish General Hospital","funders":"","keywords":"Venetoclax; Azacitidine; Myeloid leukemia; Medicine; Internal medicine; Myeloid; Oncology; Leukemia; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Conference poster reporting first results of a phase II AML treatment study; a clinical trial report."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"It reports a leukemia treatment study rather than studying research practice."},"grok":{"tier":"OUT","genre":"other","about_ca":false,"confidence":"high","reason":"AML clinical trial poster of a drug study; domain oncology trial, not research-on-research."}}}